Table TDI-11. Age at first use distributions and primary drug distributions — EU summary of clients entering treatment, 2009 or most recent year available [see all tables in this series...]

Part (i) New outpatient clients, age at first use distribution by primary drug (%)

Substance	<15	15–19	20–24	25–29	30–34	35–39	40–44	45+	Mean age	Age known (base)	Age not known
Opiates	4.9	38.1	28.2	14.1	7.5	4.0	2.0	1.3	23.0	38738	5918
Cocaine	5.1	42.1	26.1	12.5	7.5	3.8	2.0	0.9	22.5	32415	3852
Stimulants	12.1	55.7	17.6	6.9	4.2	1.9	1.0	0.6	20.1	4940	921
Hypnotics and sedatives	9.5	23.9	14.6	13.0	11.0	8.7	7.2	12.1	28.7	2295	502
Hallucinogens	7.0	55.8	22.7	9.3	2.6	1.6	0.8	0.3	20.3	387	109
Volatile substances	16.4	79.4	1.4	1.3	0.5	0.3	0.6	0.2	17.4	640	187
Cannabis	33.3	55.3	7.7	2.1	0.9	0.4	0.1	0.2	17.1	35672	10682
Other substances	16.9	43.1	15.5	5.7	5.5	4.2	1.9	7.3	23.2	1484	349
Total	14.3	45.3	20.3	9.5	5.3	2.8	1.5	1.1	21.0	116571	22520

Notes:

 Countries reporting data: BE, BG, CZ, DK, DE,EE, IE, EL, ES, FR, IT, CY, LV, HU, MT, NL, AT, PL, RO, SI, SK, FI, SE, UK, HR 

 Last data available from Spain and Poland refer to 2008. 

 The number of treatment clients in each country is listed in Table TDI-7. 

 See also Table TDI-106 on distribution by country and '‘General notes for interpreting data'’ on the Explanatory notes and help page. 

Sources:

 Reitox national reports 2010 — Table TDI — outpatient treatment centres. 

• Download this data in Excel (.xls) format

(see the help page for information about formats etc.)